Who makes the FEC75 and 95 regimen?

the FEC75 and 95 regimen is developed by Central European Cooperative Oncology Group.

What development phase is the FEC75 and 95 regimen in?

the FEC75 and 95 regimen is in Phase 2.

Last reviewed 2026-04-19 · How we verify

Central European Cooperative Oncology Group · Phase 2 active Small molecule

Generic name	the FEC75 and 95 regimen
Sponsor	Central European Cooperative Oncology Group
Modality	Small molecule
Phase	Phase 2

No approved indications tracked.

No common side effects on file.

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results